Systemic chemotherapy and breast cancer;Chimiothérapie et canccer du sein

Revue Medicale de Liege

Volumn 66, Issue 5-6, 2011, Pages 372-378

  Collignon, J ^a   Rorive, A ^a   Martin, M ^a   Andre, Ch ^a   Maweja, S ^a   Lifrange, E ^a   Coucke, Ph ^a   Jerusalem, G ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Adjuvant; Breast cancer; Chemotherapy; Metastatic; Toxic effects

Indexed keywords

ANTINEOPLASTIC AGENT;

ATTITUDE TO HEALTH; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; DRUG INDICATION; HUMAN; PATIENT SELECTION; PROGNOSIS; REVIEW; SYSTEMIC THERAPY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; BREAST TUMOR; FEMALE; METABOLISM; PATHOLOGY;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; NEOADJUVANT THERAPY; PROGNOSIS;

EID: 80051673601     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Berry DA, Cronin KA, Plevritis SK, et al - Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med, 2005, 353, 1784-1792. (Pubitemid 41549890)
2. Swain SM. - Chemotherapy : updates and new perspectives. Oncologist, 2010, 15, 8-17.
3. Perez EA. - Breast cancer management : opportunities and barriers to an individualized approach. Oncologist, 2011, 16, 20-22.
4. Goldhirsch A, Ingle JN, Gelber RD, et al. - Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer. Ann Oncol, 2009, 20, 1319-1329.
5. Taneja P, Maglic D, Kai F, et al. - Classical and novel prognostic markers for breast cancer and their clinical significance. Clin Med Insights Oncol, 2010, 4, 15-34.
6. Goldhirsch A, Wood WC, Gelber RD, et al. - Progress and promise : highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol, 2007, 18, 1133-1144. (Pubitemid 47244357)
7. Urruticoechea A, Smith IE, Dowsett M. - Proliferation marker Ki-67 in early breast cancer. J Clin Oncol, 2005, 23, 7212-7220.
8. Weigel MT, Dowsett M. - Current and emerging biomarkers in breast cancer : prognosis and prediction. Endocr Relat Cancer, 2010, 17, R245-R262.
9. Pruthi S, Brandt KR, Degnim AC, et al. - A multidisciplinary approach to the management of breast cancer, part 1: prevention and diagnosis. Mayo Clin Proc, 2007, 82, 999-1012. (Pubitemid 47206376)
10. Fisher B, Jeong JH, Bryant J, et al. - Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer : long-term findings from national surgical adju vant breast and bowel project randomised clinical trials. Lancet, 2004, 364, 858-868.
11. Galea MH, Blamey RW, Elston CE, Ellis IO. - The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat, 1992, 22, 207-219.
12. Perou CM, Sorlie T, Eisen MB, et al. - Molecular portraits of human breast tumours. Nature, 2000, 406, 747-752.
13. Sotiriou C, Pusztai L. - Gene-expression signatures in breast cancer. N Engl J Med, 2009, 360, 790-800.
14. Sorlie T, Perou CM, Tibshirani R, et al. - Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc natl acad sci USA, 2001, 98, 10869-10874. (Pubitemid 32878711)
15. Belkacemi Y, Penault-Llorca F, Gligorov J, Azria D. - The use of breast cancer subtype classification to predict local and distant recurrence. A review. Cancer Radiother, 2008, 12, 577-583.
16. Cristofanilli M, Budd GT, Ellis MJ, et al. - Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med, 2004, 351, 781-791. (Pubitemid 39095313)
17. Rack B, Schindlbeck C, Andergassen U, et al. - Prognostic relevance of circulating tumor cells in the peripheral blood of primary breast cancer patients. SABCCS 2010, Abstract 5-6.
18. Heneghan HM, Miller N, Lowery AJ, et al. - Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg, 2010, 251, 499-505.
19. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). - Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival : an overwiew of the randomised trials. Lancet, 2005, 365, 1687-1717.
20. Bonilla L, Ben-Aharon I, Vidal L, et al. - Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials. J Natl Cancer Inst, 2010, 102, 1845-1854.
21. Mauri D, Pavlidis N, Ioannidis JP. - Neoadjuvant versus adjuvant systemic treatment in breast cancer : a meta-analysis. J Natl Cancer Inst, 2005, 97, 188-194. (Pubitemid 40277368)
22. Fisher B, Brown A, Mamounas E, et al. - Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer : findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol, 1997, 15, 2483-2493. (Pubitemid 27289876)
23. Kaufmann M, von MG, Bear HD, et al. - Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer : new perspectives 2006. Ann Oncol, 2007, 18, 1927-1934.
24. Robertson FM, Bondy M, Yang W, et al. - Inflammatory breast cancer : the disease, the biology, the treatment. CA Cancer J Clin, 2010, 60, 351-375.
25. Ali D, Le SR. - Treatment of the primary tumor in breast cancer patients with synchronous metastases. Ann Oncol, 2011, 22, 9-16.
26. Pagani O, Senkus E, Wood W, et al. - International guidelines for management of metastatic breast cancer : can metastatic breast cancer be cured? J Natl Cancer Inst, 2010, 102, 456-463.
27. Beslija S, Bonneterre J, Burstein HJ, et al. - Third consensus on medical treatment of metastatic breast cancer. Ann Oncol, 2009, 20, 1771-1785.
28. Jones S, Holmes FA, O'Shaughnessy J, et al. - Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide : 7-year follow-up of US oncology research trial 9735. J Clin Oncol, 2009, 27, 1177-1183.
29. Vardy J, Wefel JS, Ahles T, et al. - Cancer and cancer-therapy related cognitive dysfunction : an international perspective from the Venice cognitive workshop. Ann Oncol, 2008, 19, 623-629. (Pubitemid 351461030)
30. Azim HA, de AE, Colozza M, et al. - Long-term toxic effects of adjuvant chemotherapy in breast cancer. Ann Oncol, 2011, Feb 2 (Epub ahead of print).
31. André Ch, Collignon J, Rorive A, et al. - Le cancer du sein chez la femme jeune. Rev Med Liège, 2011, 66, 397-400.
32. Martin M, Collignon J, Rorive A, et al. - Le cancer du sein de la femme âgée. Rev Med Liège, 2011, 66, 401-409.